Climate Change Data

SERB Pharmaceuticals

Climate Impact & Sustainability Data (2023)

Reporting Period: 2023

Environmental Metrics

Total Carbon Emissions:41,400 tCO2e/year
Scope 1 Emissions:3,966 tCO2e/year
Scope 2 Emissions:55 tCO2e/year
Scope 3 Emissions:37,365 tCO2e/year
Renewable Energy Share:42%
Total Energy Consumption:Not disclosed
Water Consumption:12.3 megalitres/year
Waste Generated:91.0 tons/year
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Patient care via sustainable business practices
  • Environmental sustainability
  • Social responsibility
  • Governance and compliance

Environmental Achievements

  • 3% reduction in total CO2 equivalent emissions per employee
  • 42% renewable energy as a percentage of total energy consumption (up from 36% in 2022)
  • 41% reduction in fertilizer (urea) use on production farm
  • Installation of new water treatment system in Wales manufacturing facility
  • Solar panels installed at Wales Manufacturing facility generating 5% of energy needs

Social Achievements

  • First annual Diversity and Inclusion week held
  • Charitable donations to various organizations
  • New Volunteer Day policy implemented, with 65 employees participating in the first year
  • Improved employee satisfaction scores in 6-monthly surveys
  • Launch and reimbursement of Voraxaze across Europe
  • Acquisition of Xuriden, a treatment for a rare metabolic disorder
  • Product donation in support of MédicAéro mission to Madagascar

Governance Achievements

  • Thorough review and update of compliance and anti-bribery and corruption (ABAC) policies
  • Development and adoption of new global policies for Contracting and Corporate Travel
  • Establishment of a new Group IT Charter
  • No ABAC incidents reported in 2023
  • Only 2 minor healthcare compliance issues investigated and addressed

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Not disclosed
Short-term Goals:
  • 100 participants in employee volunteer program in 2024

Environmental Challenges

  • Difficulty in precisely calculating Scope 3 emissions due to data limitations from suppliers
  • High Scope 3 emissions (estimated at 90% of total carbon footprint)
  • Water-intensive manufacturing process
Mitigation Strategies
  • Working with Carbometrix to develop a more comprehensive understanding of total carbon footprint, including Scope 3 emissions
  • Efforts underway to gather supplier-specific data on purchased products for future reports
  • Installation of a new water treatment system in Wales manufacturing facility
  • Working with suppliers to reduce emissions
  • Focusing on reducing fertilizer use, improving oil efficiency, and identifying CO2e lost through waste in CroFab and DigiFab production

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement
  • Working with suppliers to obtain more specific per-product data to reduce emissions

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: UN Global Compact, GHG Protocol Corporate Accounting and Reporting Standard

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • SDG 3
  • SDG 5
  • SDG 10
  • SDG 12
  • SDG 13
  • SDG 16

SERB prioritizes these SDGs based on materiality to the business and stakeholder relevance.

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Not disclosed